Sanaria Revenue and Competitors
Estimated Revenue & Valuation
- Sanaria's estimated annual revenue is currently $8.7M per year.
- Sanaria's estimated revenue per employee is $155,000
Employee Data
- Sanaria has 56 Employees.
- Sanaria grew their employee count by -22% last year.
Sanaria's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP International Projects and Strategy | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | Director, Mosquito Production | Reveal Email/Phone |
5 | Senior Director Quality | Reveal Email/Phone |
6 | Director Intellectual Property | Reveal Email/Phone |
7 | Chief Legal Officer | Reveal Email/Phone |
8 | Managing Director, Vaccine extraction, Immunology and Model Systems | Reveal Email/Phone |
9 | Sr. Director, Quality | Reveal Email/Phone |
10 | Senior Procurement Manager | Reveal Email/Phone |
Sanaria Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $3.6M | 46 | -31% | $17.5M | N/A |
#3 | $3.6M | 46 | -34% | $10.5M | N/A |
#4 | $30.2M | 156 | 0% | $69.4M | N/A |
#5 | $11.8M | 76 | -15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $8.8M | 57 | 19% | N/A | N/A |
#9 | $0.2M | 1 | -86% | N/A | N/A |
#10 | $2M | 13 | 18% | N/A | N/A |
What Is Sanaria?
Sanaria Inc. was founded in 2003. The company's mission is to develop and commercialize a malaria sporozoite vaccine against Plasmodium falciparum, the parasite responsible for more than 95 percent of malaria-associated severe illness and death world-wide, and the malaria parasite for which there is the most significant drug resistance. Sanaria plans to begin the first human trials of its Malaria Vaccine in 2009.
keywords:N/AN/A
Total Funding
56
Number of Employees
$8.7M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sanaria News
PNG's Sanaria Butler finished first in the long jump, triple jump and 400-meter dash. Nederland's Ke'Asia Hall finished second in the long...
Sanaria Inc; Nobelpharma Co; Sumaya Biotech; GenVec. Mexico Malaria Vaccines Market Breakdown by Type: Pre-Erythrocytic Vaccine; Erythrocytic...
GlaxoSmithKline plc; Sanaria Inc; Nobelpharma Co; Sumaya Biotech; GenVec. Malaria Vaccines Market Breakdown by Type: Pre-Erythrocytic Vaccine...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.1M | 56 | 24% | N/A |
#2 | $15.5M | 56 | 0% | N/A |
#3 | $3.5M | 56 | 17% | N/A |
#4 | $20.2M | 56 | 22% | N/A |
#5 | $10.3M | 56 | 0% | N/A |